A compound of Formula 1
wherein,
X represents an alkyl, alkylene, alkenyl, alkenylene, alkynyl or alkynylene group,
optionally having at least one substituent selected from the group of —OR1 and —NR1R2, or
Y represents —OTBS, —OR1, —NR1R2;
Z represents —OR3 or ═O; and
R1, R2 and R3 each independently stand for H, alkyl, alkenyl, alkynyl, aryl, heteroaryl, or heterocyclyl,
optionally in the form of enantiomers racemic mixtures, or pharmaceutically acceptable salts thereof, for use as a medicament, in particular for use in anti-viral cancer treatment in mammals and for use in treatment of benign or neoplastic genital Human Papilloma Virus associated diseases and for use in treatment of non-genital warts.
式 1 的化合物
其中
X 代表烷基、烯基、烯基、炔基或
炔烃基、
可选择具有至少一个选自-OR1 和-NR1R2 组的取代基,或
Y 代表-OTBS、-OR1、-NR1R2;
Z 代表-OR3 或 ═O;以及
R1、R2 和 R3 各自独立地代表 H、烷基、烯基、炔基、芳基、杂芳基或杂环基、
可选对映体外消旋混合物形式,或其药学上可接受的盐,用作药物,特别是用于哺乳动物的抗病毒癌症治疗,以及用于良性或肿瘤性生殖器人类乳头瘤病毒相关疾病的治疗和非生殖器疣的治疗。